chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: HPV4
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: This spontaneous report as received from a nurse practitioner refers to a patient of unknown age. The patient was vaccinated with dose 1 and dose 2 of GARDASIL. (Lot # not reported) "about 2 years ago" in July 2010 and went to the office on 19-JUL-2012 for a possible third dose of GARDASIL (Lot # not reported. No adverse effects were reported. Additional information has been requested,
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Joint swelling, Musculoskeletal pain, Neck pain, Pain in extremity
Clinical narrative: Information has been received from a pharmacist concerning a 75 year old female with allergy to penicillin, sulfa, PRILOSC, OTC) and LEVAQUIN and none pertinent medical history who on 09-APR-2012 was vaccinated with one 0.65 ml dose of ZOSTAVAX (Merck) (lot #: 671140/1266AA, expiration date unknown) subcutaneously in left arm. On 19-MAY-2012 the patient experienced in the left arm pain that was radiating up and down the arm that went up to the shoulder and neck. This was a sharp constant pain and very painful. There was no redness or swelling at the injection site. The patient's left wrist felt mildly swollen. Patient made a phone call to seek medical attention. "Hydrocodone (manufacturer unknown) for pain but it did not relieve the pain". No lab test performed. At the time of this report, patient had not recovered. Additional information is not expected.
Sex: U
Vaccine: PPV
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report has been received from an other health professional refers to a patient. The patient was vaccinated with a dose of PNEUMOVAX 23 (lot # 667269/1163A, Exp Date 10-DEC-2011) on 19-JUL-2012. No adverse effect reported. It was unknown if the patient sought medical attention. Additional information has been requested.
Age: 64.0
Sex: M
Vaccine: VARZOS
Symptoms: Activities of daily living impaired, Arthralgia
Clinical narrative: This spontaneous report has been received from a consumer who was a 64 years old male patient with high blood pressure and drug allergy to neomycin. The patient was vaccinated SC with a dose of ZOSTAVAX on 01-DEC-2012, frequency reported as  3 years. Concomitant medications included medicines for blood pressure. On 01-JAN-2012 the patient began to join pain then his knees and ankles to point where he had trouble getting his pants on. The outcome of the patient was unknown. No treatment was given for adverse event. No lab diagnostics studies performed. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age. The patient was vaccinated with dose 1 GARDASIL (lot # unknown) on an unspecified date in 2009. On 17-JUL-2012 the patient was in the office to receive dose 2 GARDASIL (lot # is unknown). No treatment information was reported. No adverse effect reported. Additional information has been requested.
Age: 66.0
Sex: M
Vaccine: VARZOS
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a patient of unknown age. The patient was subcutaneously vaccinated with lot # (670385/0231AA), 0.65 ml ZOSTAVAX (expiration 16-MAY-2012) on 24- JUL-2012. No adverse effects reported. No treatment information was reported. It was unknown if the patient sought medical attention. Additional information has been requested.
Age: 30.0
Sex: M
Vaccine: DTAP
Symptoms: Erythema, Injection site erythema, Injection site swelling, Injection site warmth, Tenderness
Clinical narrative: Received tetanus shot on Monday. Began to notice redness, heat, and abnormal swelling at injection site on Friday. Arm is tender to the touch and extremely red.
Age: 6.0
Sex: F
Vaccine: DTAP
Symptoms: Decreased appetite, Fatigue, Injected limb mobility decreased, Injection site erythema, Injection site induration
Clinical narrative: Area of vaccine was turning very red, hard to the touch, and tender and was quickly spreading the length of her arm. Over the next 24 hours the area affected expanded from the top of her shoulder down to her elbow. ROM was affected. Child was also very lethargic and tired and would not eat. 48 hours after time vaccine was give the redness and hardening expanded from her shoulder to her elbow and wrapped around her entire arm. Arm was also 2+ times larger in size than normal size.
Age: 6.0
Sex: F
Vaccine: DTAP
Symptoms: Injection site pain, Injection site swelling, Lethargy
Clinical narrative: Area of vaccine was turning very red, hard to the touch, and tender and was quickly spreading the length of her arm. Over the next 24 hours the area affected expanded from the top of her shoulder down to her elbow. ROM was affected. Child was also very lethargic and tired and would not eat. 48 hours after time vaccine was give the redness and hardening expanded from her shoulder to her elbow and wrapped around her entire arm. Arm was also 2+ times larger in size than normal size.
Age: 1.51
Sex: M
Vaccine: DTAP
Symptoms: Abnormal behaviour, Autism, Crying, Inappropriate affect
Clinical narrative: Non-stop crying.
Sex: M
Vaccine: HEP
Symptoms: Feeding disorder of infancy or early childhood, Lethargy
Clinical narrative: Lethargic, stopped feeding.
Age: 9.0
Sex: M
Vaccine: HEP, HEPA, IPV, MMR, VARCEL
Symptoms: Breath sounds abnormal, Dysphagia, Dyspnoea, Hypersensitivity, Pruritus generalised
Clinical narrative: late entry: ADDENDUM: 7/25/12 12:05pm  was called to room by interpreter stating that pt was having some difficulty breathing and c/o severe itching all over his body that alll started about 10mins ago - which is right after pt got multiple vaccines; notified Dr. and we both went to see pt; Pt c/o severe itching everywhere - raised areas noted covering neck and trunk and legs; pt reported that he couldnt stop scratching all over trunk and legs;  pt also c/o some difficulty breathing - states he is having hard time swallowing - per interpreter; Vitals:  76/46;  HR 116;  O2 sat: 86% room air;  (99% after on 3L NC); resp rate 20  12:15pm Epipen Jr 0.15mg given IM L thigh per proper protocol 12:20pm Benadryl 25mg po given;  no change in normal color;  12:25pm pt continues to wheeze, breath sounds are tight- reported by Dr.; Albuterol neb tx 0.83mg - 2 vials - given per dr order 12:30pm Epipen 0.3mg given IM R thigh per proper protocol vitals:  106/84;  HR  98;  o2 sat 100%on 3L 02 via NC;  resp rate 20reg; 12:35 - pt still c/o unable to catch his breath but has improved greatly by time EMS came to get pt; 12:40 - pt transferred to EMS via stretcher in stable condition; will be transferred for f/u;  7/26/12 - f/u - interpreter - spoke to pts mom today - pt was seen at ER until around 9pm last night; he was then sent home with some meds to treat allergic rxn - will also f/u with allergist/immunologist;
Age: 9.0
Sex: M
Vaccine: HEP, HEPA, IPV, MMR, VARCEL
Symptoms: Rash, Wheezing
Clinical narrative: late entry: ADDENDUM: 7/25/12 12:05pm  was called to room by interpreter stating that pt was having some difficulty breathing and c/o severe itching all over his body that alll started about 10mins ago - which is right after pt got multiple vaccines; notified Dr. and we both went to see pt; Pt c/o severe itching everywhere - raised areas noted covering neck and trunk and legs; pt reported that he couldnt stop scratching all over trunk and legs;  pt also c/o some difficulty breathing - states he is having hard time swallowing - per interpreter; Vitals:  76/46;  HR 116;  O2 sat: 86% room air;  (99% after on 3L NC); resp rate 20  12:15pm Epipen Jr 0.15mg given IM L thigh per proper protocol 12:20pm Benadryl 25mg po given;  no change in normal color;  12:25pm pt continues to wheeze, breath sounds are tight- reported by Dr.; Albuterol neb tx 0.83mg - 2 vials - given per dr order 12:30pm Epipen 0.3mg given IM R thigh per proper protocol vitals:  106/84;  HR  98;  o2 sat 100%on 3L 02 via NC;  resp rate 20reg; 12:35 - pt still c/o unable to catch his breath but has improved greatly by time EMS came to get pt; 12:40 - pt transferred to EMS via stretcher in stable condition; will be transferred for f/u;  7/26/12 - f/u - interpreter - spoke to pts mom today - pt was seen at ER until around 9pm last night; he was then sent home with some meds to treat allergic rxn - will also f/u with allergist/immunologist;
Age: 51.0
Sex: F
Vaccine: TDAP
Symptoms: Grip strength decreased, Muscular weakness, Pain in extremity
Clinical narrative: Left arm extremely sore after vaccination. A week later I told Dr it was still sore and was told that was normal. Several weeks later at primary Dr and said arm still sore and was told possibly a nerve was hit during injection and it should subside. Arm began to progressively get weaker and sore at times. Grip strength became weaker and lifting strength became weaker. Continued weakness from injection sight down to inner elbow area. Back at Dr to get to the bottom of the weakness and was put on prednisone. Some relief but day I stopped the pred everything was back, Weakness continued. Appt. now scheduled with a specialist.
Age: 86.0
Sex: F
Vaccine: VARZOS
Symptoms: Diarrhoea, Generalised erythema, Pruritus generalised
Clinical narrative: This spontaneous report as received from a consumer refers to his 86 years old mother with macular degeneration and no drug reactions or allergies, who in March 2012, was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (lot number not reported). No other co-suspects were reported. Concomitant therapies included unspecified blood pressure medication, vitamins and eye capsules. The patient's son reported that three months ago, in April 2012, his mother experienced severe diarrhea and red itchy patches all over her body and was currently hospitalized. The patient's son stated that his mother received her ZOSTAVAX dose without incident. Unspecified tests were performed. Unspecified lotions and creams were given as a treatment for the experience. At the time of the report, the patient's outcome was unknown. The patient sought medical attention. The relatedness for severe diarrhea and red itchy patches all over her body was not reported for ZOSTAVAX. Additional information is not expected.
Sex: U
Vaccine: VARZOS
Symptoms: No adverse event, Product reconstitution issue
Clinical narrative: This spontaneous report was received from a pharmacist refers to a patient of unknown age. The patient was vaccinated with ZOSTAVAX (lot # 671019/0749AA, exp 18-AUG-2012) which was reconstitute with expired diluent (lot# E011001, exp. FEB-2012) on 23-JUL-2012. No adverse effect reported. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Pyrexia, Urticaria
Clinical narrative: This spontaneous report as received from a physician refers to a female patient of unknown age. The patient was vaccinated with a 0.65 mL dose of ZOSTAVAX (lot # not reported) subcutaneously on an unknown date. On an unknown date the patient experienced "red welts down arm and a fever of 101 degrees". It was reported that the patient sought for unspecified medical attention and the patient was advised to take TYLENOL for fever. The outcome was reported as recovered. Additional information has been requested.
Age: 46.0
Sex: F
Vaccine: FLUX(H1N1)
Symptoms: Autopsy, Death, Pulmonary embolism
Clinical narrative: Case number PHHY2012US064538 is an initial literature report received on 26 Jul 2012. The health authority and Center for Disease Control (CDC) searched in Vaccine Adverse Event Reporting System (VAERS) to determine the safety of H1N1 from 01 Oct 2009 to 24 Nov 2009. This case refers to a 46-year-old female patient. Her medical history included of hypertension, hyperlipidemia, pulmonary embolism, deep vein thrombosis. She was vaccinated with H1N1 (manufacturer and batch number: unknown, hence conservatively taken as pandemic influenza vaccine INN) on an unspecified date between 01 Oct 2009 to 24 Nov 2009. Two days post vaccination the patient died due to pulmonary embolism. Autopsy was performed and the result was negative for H1N1 in lung tissue. No other information pertaining to this patient was available. It was stated that the deaths reported in this literature reflect a range of underlying conditions, some of which cannot be reasonably attributed to vaccination (however, it was not reported which of the death cases are ruled as a complication of underlying illness). The author also stated that it is difficult to establish a confident link between the deaths and vaccination since the time period was very less (only 2 months). The author also stated that this data could detect safety signals (new unexpected or rare events) but generally cannot be used to infer causality. It was concluded that the CDC review of reports from the Vaccine Adverse Event Reporting System showed no concerning safety signals (i.e., new, unexpected, or rare adverse events), and analysis of data from the Vaccine Safety Data Link found no increased occurrence of monitored conditions after H1N1 vaccination.
Age: 49.0
Sex: F
Vaccine: FLUX(H1N1)
Symptoms: Cardiovascular disorder, Death
Clinical narrative: Case number PHHY2012US064492 is an initial literature report received on 26 Jul 2012: The health authority and Center for Disease Control (CDC) searched in Vaccine Adverse Event Reporting System (VAERS) to determine the safety of H1N1 from 01 Oct 2009 to 24 Nov 2009. This report refers to a 49-year-old female patient. Her medical history included type 2 diabetes, stroke, chronic obstructive pulmonary disease, emphysema and substance abuse. She was vaccinated with H1N1 (manufacturer and batch number: unknown, hence conservatively taken as influenza vaccine INN) on an unspecified date between 01 Oct 2009 to 24 Nov 2009. Three days after vaccination she died due to suspected cardiovascular event (not specified). No other information pertaining to this patient was available. It was concluded that the deaths reported reflected a range of underlying conditions, some of which could not be reasonably attributed to vaccination (however, it was not reported which of the death cases are ruled as a complication of underlying illness). It was also stated that it was difficult to establish a confident link between the death and vaccination since the time period was very less (only 2 months). This data could detect safety signals (new unexpected or rare events) but generally could not be used to infer causality. CDC review of reports from the Vaccine Adverse Event Reporting System showed no concerning safety signals (i.e., unexpected, or rare adverse events), and analysis of data from the Vaccine Safety Data Link found no increased occurrence of monitored conditions after H1N1 vaccination.
Age: 77.0
Sex: M
Vaccine: FLUX(H1N1)
Symptoms: Death, Myocardial infarction
Clinical narrative: Case number PHHY2012US064602 is an initial literature report received on 26 Jul 2012: The health authority and the Center for Disease Control (CDC) searched in Vaccine Adverse Reporting System (VAERS) to determine the safety of H1N1 from 01 Oct 2009 to 24 Nov 2009. This report refers to a 77-year-old male patient. His medical history included lung cancer, atrial fibrillation, recurrent deep venous thrombosis, hypertension and hyperlipidemia. He was vaccinated with H1N1 (manufacturer and batch number: unknown, hence conservatively taken as pandemic influenza INN) on an unspecified date between 01 Oct 2009 to 24 Nov 2009. 2 days after vaccination he died due to suspected myocardial infarction. No other information pertaining to this patient was available. It was concluded that the deaths reported reflected a range of underlying conditions. some of which could not be reasonably attributed to vaccination (however, it was not reported which of the death cases are ruled as a complication of underlying illness). It was also stated that it was difficult to establish a confident link between the deaths and vaccination since the time period was very less (only 2 months). This data could detect safety signals (new unexpected or rare events) but generally could not be used to infer causality. CDC review of reports from the Vaccine Adverse Adverse Event Reporting System showed no concerning safety signals (i.e., new, unexpected or rare adverse events), and analysis of data from the Vaccine Safety Data Link found no increased occurrence of monitored conditions after H1N1 vaccination.
Age: 53.0
Sex: F
Vaccine: FLUX(H1N1)
Symptoms: Death
Clinical narrative: Case number PHHY2012US064556 is an initial literature report received on 26 Jul 2012: The health authority and Center for Disease Control (CDC) searched in Vaccine Adverse Event Reporting System (VAERS) to determine the safety of H1N1 from 01 Oct 2009 to 24 Nov 2009. This report refers to a 53-year-old female patient. Her medical history included end stage renal disease and atrial fibrillation. She was vaccinated with H1N1 (manufacturer and batch number: unknown, hence conservatively taken as pandemic influenza vaccine INN) on an unspecified date between 01 Oct 2009 to 24 Nov 2009. Five days after vaccination she died due to unexplained cause. No other information pertaining to this patient was available. It was concluded that the deaths reported reflected a range of underlying conditions, some of which could not be reasonably attributed to vaccination (however, it was not reported which of the death cases are ruled as a complication of underlying illness). It was also stated that it was difficult to establish a confident link between the deaths and vaccination since the time period was very less (only 2 months). This data could detect safety signals (new unexpected or rare events) but generally could not be used to infer causality. CDC review of reports from the Vaccine Adverse Event Reporting System showed no concerning safety signals (i.e., new, unexpected, or rare adverse events), and analysis of data from the Vaccine Safety Data Link found no increased occurrence of monitored conditions after H1N1 vaccination.
Age: 61.0
Sex: M
Vaccine: FLUX(H1N1)
Symptoms: Bacterial sepsis, Cardio-respiratory arrest, Death
Clinical narrative: Case number PHHY2012US064579 is an initial literature report received on 26 Jul 2012: The health authority and Center for Disease Control (CDC) searched in Vaccine Adverse Event Reporting System (VAERS) to determine the safety of H1N1 form 01 Oct 2009 to 24 Nov 2009. This report refers to a 61-year-old male patient. His medical history included hypertension, diabetes, peripheral vascular disease and end stage renal disease. He was vaccinated with H1N1 (manufacturer and batch number: unknown, hence conservatively taken as pandemic influenza vaccine INN) on an unspecified date between 01 Oct 2009 to 24 Nov 2009. 13 days after vaccination he experienced gram negative sepsis and cardio-respiratory arrest and died due to these events. No other information pertaining to this patient was available. It was concluded that the deaths reported reflected a range of underlying conditions, some of which could not be reasonably attributed to vaccination (however, it was not reported which of the death cases are ruled as a complication of underlying illness). It was also stated that it was difficult to establish a confident link between the deaths and vaccination since the time period was very less (only 2 months). This data could detect safety signals (new unexpected or rare events) but generally could not be used to infer causality. CDC review of reports from the Vaccine Adverse Event Reporting System showed no concerning safety signals (i.e., new, unexpected, or rare adverse events), and analysis of data from the Vaccine Safety Data Link found no increased occurrence of monitored conditions after H1N1 vaccination.
Age: 36.0
Sex: M
Vaccine: FLUX(H1N1)
Symptoms: Autopsy, Death, Respiratory failure
Clinical narrative: Case number PHHY2012US064537 is an initial literature report received on 26 Jul 2012. The health authority and Center for Disease Control (CDC) searched in Vaccine Adverse Event Reporting System (VAERS) to determine the safety of H1N1 from 01 Oct 2009 to 24 Nov 2009. This case refers to a 36-year-old male patient. He was immunocompromised. He was vaccinated with H1N1 (manufacturer and batch number: unknown, hence conservatively taken as pandemic influenza vaccine INN) on an unspecified date between 01 Oct 2009 to 24 Nov 2009. Nineteen days post vaccination the patient died due to respiratory failure. The autopsy result was under review (not available). No other information pertaining to this patient was available. It was stated that the deaths reported in this literature reflect a range of underlying conditions, some of which cannot be reasonably attributed to vaccination (however, it was not reported which of the death cases are ruled as a complication of underlying illness). The author also stated that it is difficult to establish a confident link between the deaths and vaccination since the time period was very less (only 2 months). The author also stated that this data could detect safety signals (new unexpected or rare events) but generally cannot be used to  infer causality. It was concluded that the CDC review of reports from the Vaccine Adverse Event Reporting System showed no concerning safety signals (i.e., new, unexpected, or rare adverse events), and analysis of data from the Vaccine Safety Data Link found no increased occurrence of monitored conditions after H1N1 vaccination.
Age: 19.0
Sex: F
Vaccine: FLUX(H1N1)
Symptoms: Death, Pneumonia, Respiratory failure
Clinical narrative: Case number PHHY2012US064536 is an initial literature report received on 26 Jul 2012. The health authority and Center for Disease Control (CDC) search in Vaccine Adverse Event Reporting System (VAERS) to determine the safety of H1N1 from 01 Oct 2009 to 24 Nov 2009. This case refers to a 19-year-old female patient. Medical history included of Rett Syndrome, severe muscle wasting/physical disability. She was vaccinated with H1N1 (manufacturer and batch number: unknown, hence conservatively taken as pandemic influenza vaccine INN) on an unspecified date between 01 Oct 2009 to 24 Nov 2009. Nine days post vaccination the patient died due to bilateral pneumonia and respiratory failure. No other information pertaining to this patient was available. It was stated that the deaths reported in this literature reflect a range of underlying conditions, some of which cannot be reasonably attributed to vaccination (however, it was not reported which of the death cases are ruled as a complication of underlying illness). The author also stated that it is difficult to establish a confident link between the deaths and vaccination since the time period was very less (only 2 months). The author also stated that this data could detect safety signals (new unexpected or rare events) but generally cannot be used to infer causality. It was concluded that the CDC review of reports from the Vaccine Adverse Event Reporting System showed no concerning safety signals (i.e., new, unexpected, or rare adverse events), and analysis of data from the Vaccine Safety Data Link found no increased occurrence of monitored conditions after H1N1 vaccination.
Age: 36.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Asthenia, Autoimmune disorder, Eye pain, Fatigue, Feeling abnormal
Clinical narrative: Woke up day after shot was given, had "brain fog". Was acting very silly and confused. Was unable to get out of my chair all day. Thought it was very strange since I am normally very active. That night in bed, body became very itchy, literally lost control of all my muscular movements for a short time. Woke the next day with severe headache and noticed my vision was not right. Was blurry and depth perception was off. Would eventually turn into constant dizziness in the following days. Called dr. on 1/24/12 to express my concerns. Told him of all my symptoms over the phone, and he told me not to worry about it. Symptoms got worse over next several weeks and headaches made me vomit and even had trouble walking. By the middle of Feb had bad acid reflux, very dry mouth, and anxiety that was uncontrollable. My eyes hurt so bad I would end up seeing eye dr 3 x. I could not sleep at night more than 1 hr. I began drinking so much water, I was going to the bathroom 20x a day at least. I was so nauseated, everything I ate ran through me or I would throw up. Around the end of February, I started to get tingling in my hands and feet so bad, I could not concentrate. Also, severe GI pain including yellow stools. As I write this, all my symptoms still exist except for the yellow stools.
Age: 36.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Gastrooesophageal reflux disease, Headache, Heart rate increased, Injection site pain, Myalgia
Clinical narrative: Woke up day after shot was given, had "brain fog". Was acting very silly and confused. Was unable to get out of my chair all day. Thought it was very strange since I am normally very active. That night in bed, body became very itchy, literally lost control of all my muscular movements for a short time. Woke the next day with severe headache and noticed my vision was not right. Was blurry and depth perception was off. Would eventually turn into constant dizziness in the following days. Called dr. on 1/24/12 to express my concerns. Told him of all my symptoms over the phone, and he told me not to worry about it. Symptoms got worse over next several weeks and headaches made me vomit and even had trouble walking. By the middle of Feb had bad acid reflux, very dry mouth, and anxiety that was uncontrollable. My eyes hurt so bad I would end up seeing eye dr 3 x. I could not sleep at night more than 1 hr. I began drinking so much water, I was going to the bathroom 20x a day at least. I was so nauseated, everything I ate ran through me or I would throw up. Around the end of February, I started to get tingling in my hands and feet so bad, I could not concentrate. Also, severe GI pain including yellow stools. As I write this, all my symptoms still exist except for the yellow stools.
Age: 36.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Pain, Pain in extremity, Palpitations, Paraesthesia, Pruritus
Clinical narrative: Woke up day after shot was given, had "brain fog". Was acting very silly and confused. Was unable to get out of my chair all day. Thought it was very strange since I am normally very active. That night in bed, body became very itchy, literally lost control of all my muscular movements for a short time. Woke the next day with severe headache and noticed my vision was not right. Was blurry and depth perception was off. Would eventually turn into constant dizziness in the following days. Called dr. on 1/24/12 to express my concerns. Told him of all my symptoms over the phone, and he told me not to worry about it. Symptoms got worse over next several weeks and headaches made me vomit and even had trouble walking. By the middle of Feb had bad acid reflux, very dry mouth, and anxiety that was uncontrollable. My eyes hurt so bad I would end up seeing eye dr 3 x. I could not sleep at night more than 1 hr. I began drinking so much water, I was going to the bathroom 20x a day at least. I was so nauseated, everything I ate ran through me or I would throw up. Around the end of February, I started to get tingling in my hands and feet so bad, I could not concentrate. Also, severe GI pain including yellow stools. As I write this, all my symptoms still exist except for the yellow stools.
Age: 36.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Suicidal ideation, Syncope, Tachycardia, Vision blurred, Vomiting
Clinical narrative: Woke up day after shot was given, had "brain fog". Was acting very silly and confused. Was unable to get out of my chair all day. Thought it was very strange since I am normally very active. That night in bed, body became very itchy, literally lost control of all my muscular movements for a short time. Woke the next day with severe headache and noticed my vision was not right. Was blurry and depth perception was off. Would eventually turn into constant dizziness in the following days. Called dr. on 1/24/12 to express my concerns. Told him of all my symptoms over the phone, and he told me not to worry about it. Symptoms got worse over next several weeks and headaches made me vomit and even had trouble walking. By the middle of Feb had bad acid reflux, very dry mouth, and anxiety that was uncontrollable. My eyes hurt so bad I would end up seeing eye dr 3 x. I could not sleep at night more than 1 hr. I began drinking so much water, I was going to the bathroom 20x a day at least. I was so nauseated, everything I ate ran through me or I would throw up. Around the end of February, I started to get tingling in my hands and feet so bad, I could not concentrate. Also, severe GI pain including yellow stools. As I write this, all my symptoms still exist except for the yellow stools.
Age: 36.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Abnormal behaviour, Altered visual depth perception, Anxiety, Computerised tomogram, Confusional state
Clinical narrative: Woke up day after shot was given, had "brain fog". Was acting very silly and confused. Was unable to get out of my chair all day. Thought it was very strange since I am normally very active. That night in bed, body became very itchy, literally lost control of all my muscular movements for a short time. Woke the next day with severe headache and noticed my vision was not right. Was blurry and depth perception was off. Would eventually turn into constant dizziness in the following days. Called dr. on 1/24/12 to express my concerns. Told him of all my symptoms over the phone, and he told me not to worry about it. Symptoms got worse over next several weeks and headaches made me vomit and even had trouble walking. By the middle of Feb had bad acid reflux, very dry mouth, and anxiety that was uncontrollable. My eyes hurt so bad I would end up seeing eye dr 3 x. I could not sleep at night more than 1 hr. I began drinking so much water, I was going to the bathroom 20x a day at least. I was so nauseated, everything I ate ran through me or I would throw up. Around the end of February, I started to get tingling in my hands and feet so bad, I could not concentrate. Also, severe GI pain including yellow stools. As I write this, all my symptoms still exist except for the yellow stools.
Age: 36.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Decreased activity, Disturbance in attention, Dizziness, Dry mouth, Dyspepsia
Clinical narrative: Woke up day after shot was given, had "brain fog". Was acting very silly and confused. Was unable to get out of my chair all day. Thought it was very strange since I am normally very active. That night in bed, body became very itchy, literally lost control of all my muscular movements for a short time. Woke the next day with severe headache and noticed my vision was not right. Was blurry and depth perception was off. Would eventually turn into constant dizziness in the following days. Called dr. on 1/24/12 to express my concerns. Told him of all my symptoms over the phone, and he told me not to worry about it. Symptoms got worse over next several weeks and headaches made me vomit and even had trouble walking. By the middle of Feb had bad acid reflux, very dry mouth, and anxiety that was uncontrollable. My eyes hurt so bad I would end up seeing eye dr 3 x. I could not sleep at night more than 1 hr. I began drinking so much water, I was going to the bathroom 20x a day at least. I was so nauseated, everything I ate ran through me or I would throw up. Around the end of February, I started to get tingling in my hands and feet so bad, I could not concentrate. Also, severe GI pain including yellow stools. As I write this, all my symptoms still exist except for the yellow stools.
Age: 36.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Electromyogram, Eye pain, Faeces discoloured, Feeling abnormal, Gait disturbance
Clinical narrative: Woke up day after shot was given, had "brain fog". Was acting very silly and confused. Was unable to get out of my chair all day. Thought it was very strange since I am normally very active. That night in bed, body became very itchy, literally lost control of all my muscular movements for a short time. Woke the next day with severe headache and noticed my vision was not right. Was blurry and depth perception was off. Would eventually turn into constant dizziness in the following days. Called dr. on 1/24/12 to express my concerns. Told him of all my symptoms over the phone, and he told me not to worry about it. Symptoms got worse over next several weeks and headaches made me vomit and even had trouble walking. By the middle of Feb had bad acid reflux, very dry mouth, and anxiety that was uncontrollable. My eyes hurt so bad I would end up seeing eye dr 3 x. I could not sleep at night more than 1 hr. I began drinking so much water, I was going to the bathroom 20x a day at least. I was so nauseated, everything I ate ran through me or I would throw up. Around the end of February, I started to get tingling in my hands and feet so bad, I could not concentrate. Also, severe GI pain including yellow stools. As I write this, all my symptoms still exist except for the yellow stools.
Age: 36.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Gastrointestinal pain, Gastrooesophageal reflux disease, Headache, Insomnia, Mobility decreased
Clinical narrative: Woke up day after shot was given, had "brain fog". Was acting very silly and confused. Was unable to get out of my chair all day. Thought it was very strange since I am normally very active. That night in bed, body became very itchy, literally lost control of all my muscular movements for a short time. Woke the next day with severe headache and noticed my vision was not right. Was blurry and depth perception was off. Would eventually turn into constant dizziness in the following days. Called dr. on 1/24/12 to express my concerns. Told him of all my symptoms over the phone, and he told me not to worry about it. Symptoms got worse over next several weeks and headaches made me vomit and even had trouble walking. By the middle of Feb had bad acid reflux, very dry mouth, and anxiety that was uncontrollable. My eyes hurt so bad I would end up seeing eye dr 3 x. I could not sleep at night more than 1 hr. I began drinking so much water, I was going to the bathroom 20x a day at least. I was so nauseated, everything I ate ran through me or I would throw up. Around the end of February, I started to get tingling in my hands and feet so bad, I could not concentrate. Also, severe GI pain including yellow stools. As I write this, all my symptoms still exist except for the yellow stools.
Age: 36.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Nausea, Nuclear magnetic resonance imaging, Paraesthesia, Pollakiuria, Pruritus generalised
Clinical narrative: Woke up day after shot was given, had "brain fog". Was acting very silly and confused. Was unable to get out of my chair all day. Thought it was very strange since I am normally very active. That night in bed, body became very itchy, literally lost control of all my muscular movements for a short time. Woke the next day with severe headache and noticed my vision was not right. Was blurry and depth perception was off. Would eventually turn into constant dizziness in the following days. Called dr. on 1/24/12 to express my concerns. Told him of all my symptoms over the phone, and he told me not to worry about it. Symptoms got worse over next several weeks and headaches made me vomit and even had trouble walking. By the middle of Feb had bad acid reflux, very dry mouth, and anxiety that was uncontrollable. My eyes hurt so bad I would end up seeing eye dr 3 x. I could not sleep at night more than 1 hr. I began drinking so much water, I was going to the bathroom 20x a day at least. I was so nauseated, everything I ate ran through me or I would throw up. Around the end of February, I started to get tingling in my hands and feet so bad, I could not concentrate. Also, severe GI pain including yellow stools. As I write this, all my symptoms still exist except for the yellow stools.
Age: 36.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Thirst, Vision blurred, Visual impairment, Vomiting
Clinical narrative: Woke up day after shot was given, had "brain fog". Was acting very silly and confused. Was unable to get out of my chair all day. Thought it was very strange since I am normally very active. That night in bed, body became very itchy, literally lost control of all my muscular movements for a short time. Woke the next day with severe headache and noticed my vision was not right. Was blurry and depth perception was off. Would eventually turn into constant dizziness in the following days. Called dr. on 1/24/12 to express my concerns. Told him of all my symptoms over the phone, and he told me not to worry about it. Symptoms got worse over next several weeks and headaches made me vomit and even had trouble walking. By the middle of Feb had bad acid reflux, very dry mouth, and anxiety that was uncontrollable. My eyes hurt so bad I would end up seeing eye dr 3 x. I could not sleep at night more than 1 hr. I began drinking so much water, I was going to the bathroom 20x a day at least. I was so nauseated, everything I ate ran through me or I would throw up. Around the end of February, I started to get tingling in my hands and feet so bad, I could not concentrate. Also, severe GI pain including yellow stools. As I write this, all my symptoms still exist except for the yellow stools.
Age: 16.0
Sex: F
Vaccine: HEP, HEPA, MMR, MNQ, HPVX
Symptoms: Immediate post-injection reaction, Syncope, Vision blurred
Clinical narrative: Immediately after the vaccine (HPV), the patient c/o blurry vision and fainted. The patient jerked for a few seconds at around 10:35am then woke up. The patients vital was taken at ~11:01am (NP=109/87). P=68). The patient left the clinic in safe conditions.
Age: 16.0
Sex: F
Vaccine: HEP, HEPA, MMR, MNQ, HPVX
Symptoms: Dyskinesia, Immediate post-injection reaction, Syncope, Vision blurred
Clinical narrative: Immediately after the vaccine (HPV), the patient c/o blurry vision and fainted. The patient jerked for a few seconds at around 10:35am then woke up. The patients vital was taken at ~11:01am (NP=109/87). P=68). The patient left the clinic in safe conditions.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Arthropod bite, Dry skin, Erythema, Pruritus, Skin discolouration
Clinical narrative: Information has been received from a 63 year old female consumer concerning herself with drug reactions/allergies to penicillin and sulfa and no pertinent medical history who on 02-MAR-2012 was vaccinated with a dose of ZOSTAVAX (Merck) (Lot# and route were not reported). Concomitant therapy included NORVASC. The patient reported that she experiencing extremely dry skin, and a rash everywhere on her body except her feet and head after receiving ZOSTAVAX (Merck). The patient also reported severe rectal and vaginal itching. The patient reached out to her health care physician (HCP) and they did not believe this was a case of the shingles. The patient was prescribed prednisone to counteract these symptoms. The patient had not improved and was concerned she might experience these symptoms the rest of her life. The patient was advised to work with her HCP. The patient sought medical attention by talking with a physician assistant. No lab diagnostics study was performed. Follow-up information was received from a physician's assistant concerning a 63 year old female with asthma and allergies to penicillin, sulfa, dust and ragweed. On 02-MAR-2012, the patient was vaccinated with ZOSTAVAX (Merck). Concomitant medications included NORVASC, albuterol, montelukast sodium (MSD), progesterone and ASA. She experienced rash, anal pruritis, loose stools and fatigue. The reporter indicated the events required emergency room/doctor visit. On 29-MAY-2012, stool studies were negative for ova, parasites and white blood cells. On 17-JUL-2012, a skin biopsy was performed (results pending at the time of the report). The patient had not yet recovered from the events. The physician's assistant considered the events to be medically significant. Additional information has been requested.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Anal pruritus, Asthenia, Biopsy, Biopsy skin, Blood test
Clinical narrative: Information has been received from a 63 year old female consumer concerning herself with drug reactions/allergies to penicillin and sulfa and no pertinent medical history who on 02-MAR-2012 was vaccinated with a dose of ZOSTAVAX (Merck) (Lot# and route were not reported). Concomitant therapy included NORVASC. The patient reported that she experiencing extremely dry skin, and a rash everywhere on her body except her feet and head after receiving ZOSTAVAX (Merck). The patient also reported severe rectal and vaginal itching. The patient reached out to her health care physician (HCP) and they did not believe this was a case of the shingles. The patient was prescribed prednisone to counteract these symptoms. The patient had not improved and was concerned she might experience these symptoms the rest of her life. The patient was advised to work with her HCP. The patient sought medical attention by talking with a physician assistant. No lab diagnostics study was performed. Follow-up information was received from a physician's assistant concerning a 63 year old female with asthma and allergies to penicillin, sulfa, dust and ragweed. On 02-MAR-2012, the patient was vaccinated with ZOSTAVAX (Merck). Concomitant medications included NORVASC, albuterol, montelukast sodium (MSD), progesterone and ASA. She experienced rash, anal pruritis, loose stools and fatigue. The reporter indicated the events required emergency room/doctor visit. On 29-MAY-2012, stool studies were negative for ova, parasites and white blood cells. On 17-JUL-2012, a skin biopsy was performed (results pending at the time of the report). The patient had not yet recovered from the events. The physician's assistant considered the events to be medically significant. Additional information has been requested.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Diarrhoea, Dyspnoea, Fatigue, Rash, Skin disorder
Clinical narrative: Information has been received from a 63 year old female consumer concerning herself with drug reactions/allergies to penicillin and sulfa and no pertinent medical history who on 02-MAR-2012 was vaccinated with a dose of ZOSTAVAX (Merck) (Lot# and route were not reported). Concomitant therapy included NORVASC. The patient reported that she experiencing extremely dry skin, and a rash everywhere on her body except her feet and head after receiving ZOSTAVAX (Merck). The patient also reported severe rectal and vaginal itching. The patient reached out to her health care physician (HCP) and they did not believe this was a case of the shingles. The patient was prescribed prednisone to counteract these symptoms. The patient had not improved and was concerned she might experience these symptoms the rest of her life. The patient was advised to work with her HCP. The patient sought medical attention by talking with a physician assistant. No lab diagnostics study was performed. Follow-up information was received from a physician's assistant concerning a 63 year old female with asthma and allergies to penicillin, sulfa, dust and ragweed. On 02-MAR-2012, the patient was vaccinated with ZOSTAVAX (Merck). Concomitant medications included NORVASC, albuterol, montelukast sodium (MSD), progesterone and ASA. She experienced rash, anal pruritis, loose stools and fatigue. The reporter indicated the events required emergency room/doctor visit. On 29-MAY-2012, stool studies were negative for ova, parasites and white blood cells. On 17-JUL-2012, a skin biopsy was performed (results pending at the time of the report). The patient had not yet recovered from the events. The physician's assistant considered the events to be medically significant. Additional information has been requested.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Stool analysis, Urticaria pigmentosa, Vulvovaginal pruritus
Clinical narrative: Information has been received from a 63 year old female consumer concerning herself with drug reactions/allergies to penicillin and sulfa and no pertinent medical history who on 02-MAR-2012 was vaccinated with a dose of ZOSTAVAX (Merck) (Lot# and route were not reported). Concomitant therapy included NORVASC. The patient reported that she experiencing extremely dry skin, and a rash everywhere on her body except her feet and head after receiving ZOSTAVAX (Merck). The patient also reported severe rectal and vaginal itching. The patient reached out to her health care physician (HCP) and they did not believe this was a case of the shingles. The patient was prescribed prednisone to counteract these symptoms. The patient had not improved and was concerned she might experience these symptoms the rest of her life. The patient was advised to work with her HCP. The patient sought medical attention by talking with a physician assistant. No lab diagnostics study was performed. Follow-up information was received from a physician's assistant concerning a 63 year old female with asthma and allergies to penicillin, sulfa, dust and ragweed. On 02-MAR-2012, the patient was vaccinated with ZOSTAVAX (Merck). Concomitant medications included NORVASC, albuterol, montelukast sodium (MSD), progesterone and ASA. She experienced rash, anal pruritis, loose stools and fatigue. The reporter indicated the events required emergency room/doctor visit. On 29-MAY-2012, stool studies were negative for ova, parasites and white blood cells. On 17-JUL-2012, a skin biopsy was performed (results pending at the time of the report). The patient had not yet recovered from the events. The physician's assistant considered the events to be medically significant. Additional information has been requested.
Age: 63.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Anal pruritus, Biopsy skin, Culture stool negative, Diarrhoea, Dry skin
Clinical narrative: Information has been received from a 63 year old female consumer concerning herself with drug reactions/allergies to penicillin and sulfa and no pertinent medical history who on 02-MAR-2012 was vaccinated with a dose of ZOSTAVAX (Merck) (Lot# and route were not reported). Concomitant therapy included NORVASC. The patient reported that she experiencing extremely dry skin, and a rash everywhere on her body except her feet and head after receiving ZOSTAVAX (Merck). The patient also reported severe rectal and vaginal itching. The patient reached out to her health care physician (HCP) and they did not believe this was a case of the shingles. The patient was prescribed prednisone to counteract these symptoms. The patient had not improved and was concerned she might experience these symptoms the rest of her life. The patient was advised to work with her HCP. The patient sought medical attention by talking with a physician assistant. No lab diagnostics study was performed. Follow-up information was received from a physician's assistant concerning a 63 year old female with asthma and allergies to penicillin, sulfa, dust and ragweed. On 02-MAR-2012, the patient was vaccinated with ZOSTAVAX (Merck). Concomitant medications included NORVASC, albuterol, montelukast sodium (MSD), progesterone and ASA. She experienced rash, anal pruritis, loose stools and fatigue. The reporter indicated the events required emergency room/doctor visit. On 29-MAY-2012, stool studies were negative for ova, parasites and white blood cells. On 17-JUL-2012, a skin biopsy was performed (results pending at the time of the report). The patient had not yet recovered from the events. The physician's assistant considered the events to be medically significant. Additional information has been requested.